Jiangxi Sanxin Medtec Co.,Ltd. (SHE:300453)

Jiangxi Sanxin Medtec Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,571	1,497	1,296	1,334	1,164	938.21
Other Revenue	3.54	3.85	3.66	2.38	-	2.17
Revenue	1,575	1,500	1,300	1,336	1,164	940.39
Revenue Growth (YoY)	12.10%	15.41%	-2.69%	14.75%	23.81%	30.31%
Cost of Revenue	1,022	972.05	847.27	886.52	763.96	636.23
Gross Profit	553.04	528.39	452.79	449.49	400.33	304.15
Selling, General & Admin	197.44	192.01	169.71	193.43	158.38	129.66
Research & Development	68.89	63.98	51.07	40.85	42.15	29.49
Other Operating Expenses	14.39	5.15	10.28	10.24	11.12	8.74
Operating Expenses	283.49	265.17	231.9	245.57	213.34	167.21
Operating Income	269.55	263.21	220.89	203.91	186.98	136.94
Interest Expense	-2.63	-3.11	-4.52	-2.95	-2.08	-1.45
Interest & Investment Income	12.03	12.44	16.01	5.71	2.13	2.06
Currency Exchange Gain (Loss)	2.51	2.92	0.76	1.57	1.78	0.82
Other Non Operating Income (Expenses)	0.52	-0.23	-1.15	-1.09	-4.62	0.03
EBT Excluding Unusual Items	281.99	275.24	231.98	207.16	184.19	138.4
Gain (Loss) on Sale of Investments	-12.93	-11.02	1.3	1.17	-0.46	0.09
Gain (Loss) on Sale of Assets	-0.23	0.19	0.16	0.01	-0.89	0.01
Asset Writedown	-0.4	-1.1	-0.38	-6.71	-3.22	-4.12
Other Unusual Items	21.95	12.75	19.71	23.99	15.76	19.27
Pretax Income	290.38	276.06	252.77	225.61	195.37	153.66
Income Tax Expense	30.87	28.36	29.54	26.52	23.56	24.67
Earnings From Continuing Operations	259.51	247.7	223.23	199.1	171.81	128.99
Minority Interest in Earnings	-23.23	-20.3	-16.6	-14.46	-15.9	-13.36
Net Income	236.27	227.4	206.63	184.63	155.91	115.62
Net Income to Common	236.27	227.4	206.63	184.63	155.91	115.62
Net Income Growth	5.76%	10.05%	11.92%	18.42%	34.84%	87.45%
Shares Outstanding (Basic)	516	515	518	515	507	503
Shares Outstanding (Diluted)	517	516	519	515	513	516
Shares Change (YoY)	-0.55%	-0.53%	0.71%	0.35%	-0.53%	-1.38%
EPS (Basic)	0.46	0.44	0.40	0.36	0.31	0.23
EPS (Diluted)	0.46	0.44	0.40	0.36	0.30	0.22
EPS Growth	6.34%	10.64%	11.13%	18.00%	35.56%	90.08%
Free Cash Flow	207.65	172.05	52.34	191.62	154.91	174.76
Free Cash Flow Per Share	0.40	0.33	0.10	0.37	0.30	0.34
Dividend Per Share	0.300	0.300	0.115	0.115	0.115	0.102
Dividend Growth	39.28%	159.97%	-	-	12.58%	99.80%
Gross Margin	35.12%	35.22%	34.83%	33.64%	34.38%	32.34%
Operating Margin	17.12%	17.54%	16.99%	15.26%	16.06%	14.56%
Profit Margin	15.00%	15.16%	15.89%	13.82%	13.39%	12.29%
Free Cash Flow Margin	13.19%	11.47%	4.03%	14.34%	13.31%	18.58%
EBITDA	378.68	352.32	293.65	267.06	242.54	186.78
EBITDA Margin	24.05%	23.48%	22.59%	19.99%	20.83%	19.86%
D&A For EBITDA	109.13	89.11	72.76	63.14	55.55	49.84
EBIT	269.55	263.21	220.89	203.91	186.98	136.94
EBIT Margin	17.12%	17.54%	16.99%	15.26%	16.06%	14.56%
Effective Tax Rate	10.63%	10.27%	11.68%	11.75%	12.06%	16.05%
Revenue as Reported	1,575	1,500	1,300	1,336	1,164	940.39
Advertising Expenses	-	7.52	1.97	4.66	8.16	4.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.